Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China flag China · Delayed Price · Currency is CNY
61.66
-2.77 (-4.30%)
Nov 17, 2026, 3:00 PM CST

Beijing Hotgen Biotech Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
192.28536.84282.05276.11523.491,161
Short-Term Investments
--601.145050.95-
Trading Asset Securities
875.19830.33201.51280.02888.68927.45
Cash & Short-Term Investments
1,0671,3671,085606.131,4632,089
Cash Growth
-2.35%26.04%78.95%-58.57%-29.94%445.84%
Accounts Receivable
120.14118.4891.9928.59102.0438.21
Other Receivables
4.661.364.1528.9317.0147.36
Receivables
124.8119.8496.1557.52119.0685.57
Inventory
87.4779.3685.56137.21154.25258.62
Prepaid Expenses
---0.152.6-
Other Current Assets
47.1430.6241.7138.959.2484.98
Total Current Assets
1,3271,5971,308839.911,7982,518
Property, Plant & Equipment
883.21902.191,0811,193867.94562.12
Long-Term Investments
536.07477.84827.231,4181,038441.6
Other Intangible Assets
45.8348.5252.1255.0756.5557.33
Long-Term Deferred Tax Assets
36.9235.4126.6434.438.815.95
Long-Term Deferred Charges
18.0320.1525.7724.323.222.32
Other Long-Term Assets
99.8798.7729.546.7676.2127.85
Total Assets
2,9473,1803,3513,5723,8993,645

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
90.7849.8149.744.72151.52141.27
Accrued Expenses
22.2738.6632.6725.55177.68167.53
Short-Term Debt
-50.0242.66---
Current Portion of Leases
0.010.340.127.4927.9513
Current Income Taxes Payable
2.80.931.061.151.13120.24
Current Unearned Revenue
15.2713.1416.728.0856.98267.05
Other Current Liabilities
34.7695.15141.9181.0596.0625.08
Total Current Liabilities
165.89248.03284.81188.04511.31734.16
Long-Term Leases
0.040.130.127.7614.1822.98
Long-Term Unearned Revenue
22.1911.0715.759.7710.779.47
Long-Term Deferred Tax Liabilities
-0.01--9.324.41
Other Long-Term Liabilities
275.58264.05----
Total Liabilities
463.7523.29300.69205.57545.59771.01

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
92.7592.7192.4792.2792.0562.2
Additional Paid-In Capital
242.43163.82334.61444.04435.31458.31
Retained Earnings
2,3362,5452,7612,9942,9582,323
Treasury Stock
-363.86-338.55-133.89-166.48-150.04-
Comprehensive Income & Other
53.423.369.964.32-0.03-0.3
Total Common Equity
2,3612,4863,0643,3683,3352,844
Minority Interest
122.29170.32-14.16-2.1218.4630.31
Shareholders' Equity
2,4832,6573,0503,3663,3542,874
Total Liabilities & Equity
2,9473,1803,3513,5723,8993,645

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.0550.4942.915.2642.1335.98
Net Cash (Debt)
1,0671,3171,042590.871,4212,053
Net Cash Growth
2.34%26.39%76.31%-58.42%-30.77%436.43%
Net Cash Per Share
11.2314.3811.956.6915.4622.30
Filing Date Shares Outstanding
88.1787.9389.5889.4189.5392.05
Total Common Shares Outstanding
88.1787.9389.5889.4189.5392.05
Working Capital
1,1611,3491,023651.881,2871,784
Book Value Per Share
26.7828.2834.2037.6737.2530.89
Tangible Book Value
2,3152,4383,0123,3133,2792,786
Tangible Book Value Per Share
26.2627.7233.6237.0636.6230.27
Buildings
-616.65703.6704.79174.55162.16
Machinery
-543.25581.09575.66399.88317.94
Construction In Progress
-0.125.6248.18374.44121.71